1. 1292PPhase I study of cemiplimab, a human monoclonal anti-PD-1, in patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Longer follow-up efficacy and safety data. (23rd October 2018) Authors: Owonikoko, T K; Papadopoulos, K P; Gil-Martin, M; Moreno, V; Salama, A K; Calvo, E; Safran, H; González-Martín, A; Aljumaily, R; Mahadevan, D; Niu, J; Kal Mohan, K; Li, J; Stankevich, E; Mathias, M; Lowy, I; Fury, M G; Babiker, H M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 71PPhase I study of cemiplimab, a human monoclonal anti-PD-1, in patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Longer follow-up efficacy and safety data. (17th December 2018) Authors: Owonikoko, T K; Papadopoulos, K P; Johnson, M L; Gil Martín, M; Moreno, V; Salama, A K; Calvo, E; Yee, N S; Safran, H; Aljumaily, R; Mahadevan, D; Niu, J; Kal Mohan, K; Li, J; Stankevich, E; Mathias, M; Lowy, I; Fury, M G; Babiker, H M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 74PPhase I expansion cohort results of cemiplimab, a human PD-1 monoclonal antibody, in combination with radiotherapy (RT), cyclophosphamide and GM-CSF, in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). (17th December 2018) Authors: Babiker, H M; Brana, I; Mahadevan, D; Owonikoko, T K; Calvo, E; Rischin, D; Moreno, V; Papadopoulos, K P; Crittenden, M; Formenti, S; Giralt, J; Garrido, P; Hervás Morón, A; Mohan, K K; Fury, M G; Lowy, I; Stankevich, E; Feng, M; Li, J; Mathias, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1778 Preeclampsia is associated with reduced myocardial work efficiency during pregnancy. (17th January 2020) Authors: Chow, Y Y; Chapman, M; Mahadevan, D; Dekker, G; Arstall, M Journal: European heart journal Issue: Volume 21(2020)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗